Tuberculosis in Hong Kong ten years later.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D001500:BCG Vaccine; D002675:Child, Preschool; D002681:China; D003523:Cycloserine / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D005000:Ethionamide / Q000627:therapeutic use; D006266:Health Education; D006723:Hong Kong; D006760:Hospitalization; D006801:Humans; D006967:Hypersensitivity / Q000175:diagnosis; D007223:Infant; D007226:Infant Mortality; D007231:Infant, Newborn; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D044469:Racial Groups; D012106:Research; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control
D000636:Aminosalicylic Acids; D001500:BCG Vaccine; D011718:Pyrazinamide; D003523:Cycloserine; D005000:Ethionamide; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin